A detailed history of Cable Hill Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cable Hill Partners, LLC holds 3,982 shares of ABBV stock, worth $729,024. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,982
Previous 4,003 0.52%
Holding current value
$729,024
Previous $686,000 14.58%
% of portfolio
0.08%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.84 - $199.33 $3,440 - $4,185
-21 Reduced 0.52%
3,982 $786,000
Q2 2024

Jul 22, 2024

BUY
$154.79 - $180.76 $619,624 - $723,582
4,003 New
4,003 $686,000
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $18,702 - $21,651
140 Added 2.4%
5,976 $890,000
Q2 2023

Jul 19, 2023

BUY
$132.51 - $164.9 $2,915 - $3,627
22 Added 0.38%
5,836 $786,000
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $167,747 - $193,186
-1,160 Reduced 16.63%
5,814 $926,000
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $19,778 - $23,719
-143 Reduced 2.01%
6,974 $1.13 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $23,620 - $27,091
176 Added 2.54%
7,117 $955,000
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $437,493 - $556,197
3,179 Added 84.5%
6,941 $1.06 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $10,822 - $13,427
-82 Reduced 2.13%
3,762 $610,000
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $39,534 - $50,022
-368 Reduced 8.74%
3,844 $520,000
Q3 2021

Nov 16, 2021

BUY
$106.4 - $120.78 $15,960 - $18,117
150 Added 3.69%
4,212 $454,000
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $13,677 - $15,237
-130 Reduced 3.1%
4,062 $458,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $29,667 - $32,659
290 Added 7.43%
4,192 $454,000
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $7,405 - $9,997
-92 Reduced 2.3%
3,902 $418,000
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $28,264 - $33,173
329 Added 8.98%
3,994 $350,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $29,714 - $39,762
405 Added 12.42%
3,665 $360,000
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $14,448 - $21,904
-224 Reduced 6.43%
3,260 $248,000
Q4 2019

Feb 04, 2020

SELL
$72.13 - $90.25 $35,776 - $44,764
-496 Reduced 12.46%
3,484 $308,000
Q3 2019

Oct 29, 2019

SELL
$62.98 - $75.72 $51,958 - $62,469
-825 Reduced 17.17%
3,980 $301,000
Q2 2019

Aug 06, 2019

SELL
$65.7 - $83.98 $35,215 - $45,013
-536 Reduced 10.04%
4,805 $349,000
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $308 - $363
4 Added 0.07%
5,341 $430,000
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $53,794 - $66,342
691 Added 14.87%
5,337 $492,000
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $1,333 - $1,482
-15 Reduced 0.32%
4,646 $436,000
Q2 2018

Aug 03, 2018

SELL
$89.78 - $106.23 $26,574 - $31,444
-296 Reduced 5.97%
4,661 $432,000
Q1 2018

Apr 20, 2018

SELL
$92.01 - $123.21 $401,623 - $537,811
-4,365 Reduced 46.82%
4,957 $445,000
Q4 2017

Feb 22, 2018

BUY
$89.56 - $98.21 $20,598 - $22,588
230 Added 2.53%
9,322 $926,000
Q3 2017

Oct 27, 2017

BUY
$69.85 - $89.22 $445,503 - $569,045
6,378 Added 235.0%
9,092 $808,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,714
2,714 $197,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cable Hill Partners, LLC Portfolio

Follow Cable Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.